One study demonstrated that GLP-1 can activate LTP in the brain and ameliorate cognitive dysfunction in a neurodegenerative disorder model (McClean et al., 2011)
It might matter for the pill
The FDCA defines labeling broadly to mean all labels and other written, printed or graphic matter.[26] The FDA and the Supreme Court have broadly interpreted labeling to apply to marketing and advertising materials, including advertisements.[27] We look forward to further dialogue with you both regarding the urgent need for FDA to take action against compounded drug advertisements that fail to comply with FDA laws, regulations, and guidance
[14] [13] These mechanisms contribute to improved glycaemic control and weight loss, but they can also lead to reduced caloric intake, changes in eating patterns, and occasionally low blood glucose levels (hypoglycaemia), all of which may contribute to feelings of tiredness
The focus now is on making GLP-1 investments work harder with the right clinical oversight, nutrition support, and a plan for sustaining outcomes over time
Takatsuka and Umeda 2014